2017
2432
Huang Y, Brown S, Ma S, Kyriakides T. 2432. Journal Of Clinical And Translational Science 2017, 1: 37-37. PMCID: PMC6799711, DOI: 10.1017/cts.2017.137.Peer-Reviewed Original ResearchAdvanced HIV diseaseARV medicationsHIV diseaseVirtual phenotypeSubsequent managementARV treatment strategiesEffects of ARVHIV treatment trialsIndividual ARV drugsCD4 cell countAnti-retroviral drugsCurrent clinical practiceOpen labelSpecific ARVsStandard armARV regimenIntensive armViral loadTherapeutic optionsVital statusARV drugsTreatment trialsARV treatmentTreatment strategiesTrial randomization
2011
Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial
Holodniy M, Brown ST, Cameron DW, Kyriakides TC, Angus B, Babiker A, Singer J, Owens DK, Anis A, Goodall R, Hudson F, Piaseczny M, Russo J, Schechter M, Deyton L, Darbyshire J, . Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial. PLOS ONE 2011, 6: e14764. PMID: 21483491, PMCID: PMC3069000, DOI: 10.1371/journal.pone.0014764.Peer-Reviewed Original ResearchConceptsRe-treatment optionsART interruptionHIV infectionPrimary outcomeRetreatment optionsMultidrug resistanceAdvanced HIV diseaseAntiretroviral treatment interruptionARV treatment failurePrior AIDS diagnosisResistant HIV InfectionMedian CD4 countPrimary composite outcomeSerious adverse eventsMean viral loadBest medical managementOPTIMA trialCD4 countOpen labelTreatment interruptionAdverse eventsComposite outcomeFirst AIDSHIV diseaseAntiretroviral treatment